Clinical Trial Update: Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updates biomarkers associated with the efficacy of an anti-TNFα agent in ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Snippet

Sponsor: Universidade Nova de Lisboa | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED